245 related articles for article (PubMed ID: 29542045)
21. Optos-guided pattern scan laser (Pascal)-targeted retinal photocoagulation in proliferative diabetic retinopathy.
Muqit MM; Marcellino GR; Henson DB; Young LB; Patton N; Charles SJ; Turner GS; Stanga PE
Acta Ophthalmol; 2013 May; 91(3):251-8. PubMed ID: 22176513
[TBL] [Abstract][Full Text] [Related]
22. [Electroretinogram before and after panretinal photocoagulation in diabetic retinopathy].
Hoshino I
Nippon Ganka Gakkai Zasshi; 1995 Aug; 99(8):925-31. PubMed ID: 7676893
[TBL] [Abstract][Full Text] [Related]
23. Results of Treatment of Diabetic Retinopathy by the Laser System PASCAL.
Němčanský J; Stepanov A; Němčanská S; Langrová H; Studnička J
Cesk Slov Oftalmol; 2018; 73(5-6):198-203. PubMed ID: 30541300
[TBL] [Abstract][Full Text] [Related]
24. Pan retinal photocoagulation for proliferative diabetic retinopathy: pattern scan laser versus argon laser.
Alasil T; Waheed NK
Curr Opin Ophthalmol; 2014 May; 25(3):164-70. PubMed ID: 24663066
[TBL] [Abstract][Full Text] [Related]
25. Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy.
Filho JA; Messias A; Almeida FP; Ribeiro JA; Costa RA; Scott IU; Jorge R
Acta Ophthalmol; 2011 Nov; 89(7):e567-72. PubMed ID: 21726427
[TBL] [Abstract][Full Text] [Related]
26. Reading deficits in diabetic patients treated with panretinal photocoagulation and good visual acuity.
Omari A; Niziol LM; Gardner TW
Acta Ophthalmol; 2019 Nov; 97(7):e1013-e1018. PubMed ID: 30968579
[TBL] [Abstract][Full Text] [Related]
27. Long-term effects of pattern scan laser pan-retinal photocoagulation on diabetic retinopathy in Chinese patients: a retrospective study.
Huang CX; Lai KB; Zhou LJ; Tian Z; Zhong XJ; Xu FB; Gong YJ; Lu L; Jin CJ
Int J Ophthalmol; 2020; 13(2):239-245. PubMed ID: 32090032
[TBL] [Abstract][Full Text] [Related]
28. Single-Dose Intravitreal Conbercept before Panretinal Photocoagulation as an Effective Adjunctive Treatment in Chinese Proliferative Diabetic Retinopathy.
Zhang Q; Zhang T; Zhuang H; Sun Z; Qin Y
Ophthalmologica; 2019; 242(2):59-68. PubMed ID: 30699427
[TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of panretinal photocoagulation in patients with high-risk proliferative diabetic retinopathy using pattern scan laser versus conventional YAG laser.
Seymenoğlu RG; Ulusoy MO; Başer EF
Kaohsiung J Med Sci; 2016 Jan; 32(1):22-6. PubMed ID: 26853171
[TBL] [Abstract][Full Text] [Related]
30. Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure.
Boynton GE; Stem MS; Kwark L; Jackson GR; Farsiu S; Gardner TW
Ophthalmology; 2015 May; 122(5):957-67. PubMed ID: 25601533
[TBL] [Abstract][Full Text] [Related]
31. Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
; Gross JG; Glassman AR; Jampol LM; Inusah S; Aiello LP; Antoszyk AN; Baker CW; Berger BB; Bressler NM; Browning D; Elman MJ; Ferris FL; Friedman SM; Marcus DM; Melia M; Stockdale CR; Sun JK; Beck RW
JAMA; 2015 Nov; 314(20):2137-2146. PubMed ID: 26565927
[TBL] [Abstract][Full Text] [Related]
32. [Comparison of outcomes of conventional laser versus pascal laser for diabetic retinopathy].
Yamakawa M; Nozaki M; Sato R; Morita H; Yoshida M; Ogura Y
Nippon Ganka Gakkai Zasshi; 2014 Apr; 118(4):362-7. PubMed ID: 24864435
[TBL] [Abstract][Full Text] [Related]
33. Patient Comfort with Yellow (577 nm) vs. Green (532 nm) Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy.
Adam MK; Weinstock BM; Kasi SK; Ehmann DS; Hsu J; Garg SJ; Ho AC; Chiang A
Ophthalmol Retina; 2018 Feb; 2(2):91-95. PubMed ID: 31047351
[TBL] [Abstract][Full Text] [Related]
34. The Effect of Multispot Laser Panretinal Photocoagulation on Retinal Sensitivity and Driving Eligibility in Patients With Diabetic Retinopathy.
Subash M; Comyn O; Samy A; Qatarneh D; Antonakis S; Mehat M; Tee J; Mansour T; Xing W; Bunce C; Viswanathan A; Rubin G; Weleber R; Peto T; Wickham L; Michaelides M
JAMA Ophthalmol; 2016 Jun; 134(6):666-72. PubMed ID: 27077924
[TBL] [Abstract][Full Text] [Related]
35. Intravitreal bevacizumab (Avastin) prevention of panretinal photocoagulation-induced complications in patients with severe proliferative diabetic retinopathy.
Mason JO; Yunker JJ; Vail R; McGwin G
Retina; 2008 Oct; 28(9):1319-24. PubMed ID: 18667958
[TBL] [Abstract][Full Text] [Related]
36. [Changes in the electroretinogram of eyes with diabetic retinopathy treated by vitrectomy].
Arima M
Nippon Ganka Gakkai Zasshi; 1997 Jul; 101(7):575-83. PubMed ID: 9256619
[TBL] [Abstract][Full Text] [Related]
37. Single session of pattern scanning laser versus multiple sessions of conventional laser for panretinal photocoagulation in diabetic retinopathy: Efficacy, safety and painfulness.
Nemcansky J; Stepanov A; Nemcanska S; Masek P; Langrova H; Studnicka J
PLoS One; 2019; 14(7):e0219282. PubMed ID: 31310626
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of Intravitreous Ranibizumab Compared With Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Secondary Analysis From a Diabetic Retinopathy Clinical Research Network Randomized Clinical Trial.
Hutton DW; Stein JD; Bressler NM; Jampol LM; Browning D; Glassman AR;
JAMA Ophthalmol; 2017 Jun; 135(6):576-584. PubMed ID: 28492920
[TBL] [Abstract][Full Text] [Related]
39. Diabetic Nephropathy in Type 2 Diabetic Retinopathy Requiring Panretinal Photocoagulation.
Ha M; Choi SY; Kim M; Na JK; Park YH
Korean J Ophthalmol; 2019 Feb; 33(1):46-53. PubMed ID: 30746911
[TBL] [Abstract][Full Text] [Related]
40. Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.
Shimura M; Yasuda K; Shiono T
Ophthalmology; 2006 Mar; 113(3):381-7. PubMed ID: 16458970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
